Fosun Pharmaceutical Shares Fall 8% on Hong Kong Debut

HONG KONG—Drug maker Shanghai Fosun Pharmaceutical (Group) Co., which raised $512 million in the first major initial public offering in Hong Kong in months, saw its shares fall 8% on their debut Tuesday, signaling that demand for new share sales has yet …

Share